Hypoxia in models of lung cancer: Implications for targeted therapeutics

Edward E. Graves, Marta Vilalta, Ivana K. Cecic, Janine T. Erler, Phuoc T Tran, Dean Felsher, Leanne Sayles, Alejandro Sweet-Cordero, Quynh Thu Le, Amato J. Giaccia

Research output: Contribution to journalArticle

Abstract

Purpose: To efficiently translate experimental methods from bench to bedside, it is imperative that laboratory models of cancer mimic human disease as closely as possible. In this study, we sought to compare patterns of hypoxia in several standard and emerging mouse models of lung cancer to establish the appropriateness of each for evaluating the role of oxygen in lung cancer progression and therapeutic response. Experimental Design: Subcutaneous and orthotopic human A549 lung carcinomas growing in nude mice as well as spontaneous K-ras or Myc-induced lung tumors grown in situ or subcutaneously were studied using fluorodeoxyglucose and fluoroazomycin arabinoside positron emission tomography, and postmortem by immunohistochemical observation of the hypoxia marker pimonidazole. The response of these models to the hypoxia-activated cytotoxin PR-104 was also quantified by the formation of ãH2AX foci in vitro and in vivo. Finally, our findings were compared with oxygen electrode measurements of human lung cancers. Results: Minimal fluoroazomycin arabinoside and pimonidazole accumulation was seen in tumors growing within the lungs, whereas subcutaneous tumors showed substantial trapping of both hypoxia probes. These observations correlated with the response of these tumors to PR-104, and with the reduced incidence of hypoxia in human lung cancers relative to other solid tumor types. Conclusions: These findings suggest that in situ models of lung cancer in mice may be more reflective of the human disease, and encourage judicious selection of preclinical tumor models for the study of hypoxia imaging and antihypoxic cell therapies.

Original languageEnglish (US)
Pages (from-to)4843-4852
Number of pages10
JournalClinical Cancer Research
Volume16
Issue number19
DOIs
StatePublished - Oct 1 2010
Externally publishedYes

Fingerprint

Lung Neoplasms
Neoplasms
Lung
Therapeutics
Oxygen
Cytotoxins
Cell- and Tissue-Based Therapy
Hypoxia
Nude Mice
Positron-Emission Tomography
Electrodes
Research Design
Observation
Carcinoma
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Graves, E. E., Vilalta, M., Cecic, I. K., Erler, J. T., Tran, P. T., Felsher, D., ... Giaccia, A. J. (2010). Hypoxia in models of lung cancer: Implications for targeted therapeutics. Clinical Cancer Research, 16(19), 4843-4852. https://doi.org/10.1158/1078-0432.CCR-10-1206

Hypoxia in models of lung cancer : Implications for targeted therapeutics. / Graves, Edward E.; Vilalta, Marta; Cecic, Ivana K.; Erler, Janine T.; Tran, Phuoc T; Felsher, Dean; Sayles, Leanne; Sweet-Cordero, Alejandro; Le, Quynh Thu; Giaccia, Amato J.

In: Clinical Cancer Research, Vol. 16, No. 19, 01.10.2010, p. 4843-4852.

Research output: Contribution to journalArticle

Graves, EE, Vilalta, M, Cecic, IK, Erler, JT, Tran, PT, Felsher, D, Sayles, L, Sweet-Cordero, A, Le, QT & Giaccia, AJ 2010, 'Hypoxia in models of lung cancer: Implications for targeted therapeutics', Clinical Cancer Research, vol. 16, no. 19, pp. 4843-4852. https://doi.org/10.1158/1078-0432.CCR-10-1206
Graves, Edward E. ; Vilalta, Marta ; Cecic, Ivana K. ; Erler, Janine T. ; Tran, Phuoc T ; Felsher, Dean ; Sayles, Leanne ; Sweet-Cordero, Alejandro ; Le, Quynh Thu ; Giaccia, Amato J. / Hypoxia in models of lung cancer : Implications for targeted therapeutics. In: Clinical Cancer Research. 2010 ; Vol. 16, No. 19. pp. 4843-4852.
@article{eed1376e5de34d9ea6eafcd98500e335,
title = "Hypoxia in models of lung cancer: Implications for targeted therapeutics",
abstract = "Purpose: To efficiently translate experimental methods from bench to bedside, it is imperative that laboratory models of cancer mimic human disease as closely as possible. In this study, we sought to compare patterns of hypoxia in several standard and emerging mouse models of lung cancer to establish the appropriateness of each for evaluating the role of oxygen in lung cancer progression and therapeutic response. Experimental Design: Subcutaneous and orthotopic human A549 lung carcinomas growing in nude mice as well as spontaneous K-ras or Myc-induced lung tumors grown in situ or subcutaneously were studied using fluorodeoxyglucose and fluoroazomycin arabinoside positron emission tomography, and postmortem by immunohistochemical observation of the hypoxia marker pimonidazole. The response of these models to the hypoxia-activated cytotoxin PR-104 was also quantified by the formation of {\~a}H2AX foci in vitro and in vivo. Finally, our findings were compared with oxygen electrode measurements of human lung cancers. Results: Minimal fluoroazomycin arabinoside and pimonidazole accumulation was seen in tumors growing within the lungs, whereas subcutaneous tumors showed substantial trapping of both hypoxia probes. These observations correlated with the response of these tumors to PR-104, and with the reduced incidence of hypoxia in human lung cancers relative to other solid tumor types. Conclusions: These findings suggest that in situ models of lung cancer in mice may be more reflective of the human disease, and encourage judicious selection of preclinical tumor models for the study of hypoxia imaging and antihypoxic cell therapies.",
author = "Graves, {Edward E.} and Marta Vilalta and Cecic, {Ivana K.} and Erler, {Janine T.} and Tran, {Phuoc T} and Dean Felsher and Leanne Sayles and Alejandro Sweet-Cordero and Le, {Quynh Thu} and Giaccia, {Amato J.}",
year = "2010",
month = "10",
day = "1",
doi = "10.1158/1078-0432.CCR-10-1206",
language = "English (US)",
volume = "16",
pages = "4843--4852",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Hypoxia in models of lung cancer

T2 - Implications for targeted therapeutics

AU - Graves, Edward E.

AU - Vilalta, Marta

AU - Cecic, Ivana K.

AU - Erler, Janine T.

AU - Tran, Phuoc T

AU - Felsher, Dean

AU - Sayles, Leanne

AU - Sweet-Cordero, Alejandro

AU - Le, Quynh Thu

AU - Giaccia, Amato J.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Purpose: To efficiently translate experimental methods from bench to bedside, it is imperative that laboratory models of cancer mimic human disease as closely as possible. In this study, we sought to compare patterns of hypoxia in several standard and emerging mouse models of lung cancer to establish the appropriateness of each for evaluating the role of oxygen in lung cancer progression and therapeutic response. Experimental Design: Subcutaneous and orthotopic human A549 lung carcinomas growing in nude mice as well as spontaneous K-ras or Myc-induced lung tumors grown in situ or subcutaneously were studied using fluorodeoxyglucose and fluoroazomycin arabinoside positron emission tomography, and postmortem by immunohistochemical observation of the hypoxia marker pimonidazole. The response of these models to the hypoxia-activated cytotoxin PR-104 was also quantified by the formation of ãH2AX foci in vitro and in vivo. Finally, our findings were compared with oxygen electrode measurements of human lung cancers. Results: Minimal fluoroazomycin arabinoside and pimonidazole accumulation was seen in tumors growing within the lungs, whereas subcutaneous tumors showed substantial trapping of both hypoxia probes. These observations correlated with the response of these tumors to PR-104, and with the reduced incidence of hypoxia in human lung cancers relative to other solid tumor types. Conclusions: These findings suggest that in situ models of lung cancer in mice may be more reflective of the human disease, and encourage judicious selection of preclinical tumor models for the study of hypoxia imaging and antihypoxic cell therapies.

AB - Purpose: To efficiently translate experimental methods from bench to bedside, it is imperative that laboratory models of cancer mimic human disease as closely as possible. In this study, we sought to compare patterns of hypoxia in several standard and emerging mouse models of lung cancer to establish the appropriateness of each for evaluating the role of oxygen in lung cancer progression and therapeutic response. Experimental Design: Subcutaneous and orthotopic human A549 lung carcinomas growing in nude mice as well as spontaneous K-ras or Myc-induced lung tumors grown in situ or subcutaneously were studied using fluorodeoxyglucose and fluoroazomycin arabinoside positron emission tomography, and postmortem by immunohistochemical observation of the hypoxia marker pimonidazole. The response of these models to the hypoxia-activated cytotoxin PR-104 was also quantified by the formation of ãH2AX foci in vitro and in vivo. Finally, our findings were compared with oxygen electrode measurements of human lung cancers. Results: Minimal fluoroazomycin arabinoside and pimonidazole accumulation was seen in tumors growing within the lungs, whereas subcutaneous tumors showed substantial trapping of both hypoxia probes. These observations correlated with the response of these tumors to PR-104, and with the reduced incidence of hypoxia in human lung cancers relative to other solid tumor types. Conclusions: These findings suggest that in situ models of lung cancer in mice may be more reflective of the human disease, and encourage judicious selection of preclinical tumor models for the study of hypoxia imaging and antihypoxic cell therapies.

UR - http://www.scopus.com/inward/record.url?scp=77957564889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957564889&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-10-1206

DO - 10.1158/1078-0432.CCR-10-1206

M3 - Article

C2 - 20858837

AN - SCOPUS:77957564889

VL - 16

SP - 4843

EP - 4852

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 19

ER -